TOGIAC, NCT04888221: Efficacy of Tocilizumab in Association to Steroids in Giant Cell Arteritis With Cerebro-vascular Involvement |
|
|
| Recruiting | 3 | 66 | Europe | Tocilizumab, RoActemra, Actemra, Placebo | Assistance Publique - Hôpitaux de Paris, Roche Chugai, Roche Pharma AG | Giant Cell Arteritis, Neurovascular Disorder | 03/25 | 10/25 | | |
CLOSE-2, NCT05387954: PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years |
|
|
| Recruiting | 3 | 792 | Europe | Transcatheter PFO closure, •Each device for PFO closure must have the CE mark, •and be approved by the Interventional Cardiology Committee, Oral Anticoagulant, Direct-Acting, Antiplatelet therapy | Assistance Publique - Hôpitaux de Paris, Ministry of Health, France, W.L.Gore & Associates, Abbott, Occlutech International AB, Centre Hospitalier St Anne | Cryptogenic Ischemic Stroke, Patent Foramen Ovale | 07/31 | 07/31 | | |
